598
Views
23
CrossRef citations to date
0
Altmetric
Original Article

Fetal fibronectin as a predictor of spontaneous preterm birth: a European perspective

, , , , , , , , , & show all
Pages 330-336 | Accepted 04 May 2010, Published online: 29 Jul 2010

References

  • March of Dimes White Paper on Preterm Birth. March of Dimes Foundation. NewYork, 2009. http://www.marchofdimes.com/.
  • Slattery MM, Morrison JJ. Preterm delivery. Lancet 2002;360:1489–1497.
  • Chandiramani M, Shennan AH. Preterm labour: update on prediction and prevention strategies. Curr Opin Obstet Gynecol 2006;18:618–624.
  • Di Renzo GC, Roura LC. Guidelines for the management of spontaneous preterm labor. J Perinatal Med 2006;34:359–366.
  • Langhoff-Roos J, Kesmodel U, Jacobsson B, Rasmussen S, Vogel I. Spontaneous preterm delivery in primiparous women at low risk in Denmark: population-based study. BMJ 2006;332:937–939.
  • Steer P. The epidemiology of preterm labour. BJOG 2005;112:1–3.
  • Tekesin I, Marek S, Hellmeyer L, et al. Assessment of rapid fetal fibronectin in predicting preterm delivery. Obstet Gynecol 2005;105:280–284.
  • CDC. Preliminary births for 2004. 2005. http://www.cdc.gov/nchs/product/pubs/pubd/hcstats/prelimbirths04/prelimbirths 10/12/2009.
  • Chandiramani M, Tribe RM, Shennan AH. Preterm labour and prematurity. Obstet Gynaecol Reprod Med 2007;17:232–237.
  • Ness A, Visintine J, Ricci E, et al. Does knowledge of cervical length and fetal fibronectin affect management of women with threatened preterm labor? A randomized trial. Am J Obstet Gynecol 2007;197:426.e1–426.e7.
  • Giles W, Bisits A, Knox M, et al. The effect of fetal fibronectin testing on admissions to a tertiary maternal-fetal medicine unit and cost savings. Am J Obstet Gynecol 2000;2:438–444.
  • Lopez RL, Francis JA, Garite TJ, et al. Fetal fibronectin detection as a predictor of preterm birth in actual clinical practice. Am J Obstet Gynecol 2001;182:1103–1106.
  • Goffinet F. Primary predictors of preterm labour. BJOG 2005;112:38–47.
  • Hassan SS, Romero R, Berry SM, et al. Patients with an ultrasonographic cervical length ≤15mm have nearly a 50% risk of early spontaneous preterm delivery. Am J Obstet Gynecol 2000;182:1458–1467.
  • Daskalakis G, Thomakos N, Hatziioannou L, et al. Cervical assessment in women with threatened preterm labor. J Matern Fetal Neonatal Med 2005;17:309–312.
  • Assessment of risk factors for preterm birth. ACOG Practice Bulletin. Number 31. American College of Obstetricians and Gynecologists. Obstet Gynecol 2001;98:709–716.
  • Sonek JD, Iams JD, Blumenfeld M, et al. Measurement of cervical length in pregnancy: comparison between vaginal ultrasonography and digital examination. Obstet Gynecol 1990;76:172–175.
  • Markenson G, Bsat F. Predicting preterm labor. Female Patient 2008;33:19–25.
  • Romero R, Espinoza J, Erez O, et al. The role of cervical cerclage in obstetric practice: can the patient who could benefit from this procedure be identified?. Am J Obstet Gynecol 2006;194:1–9.
  • Goldenberg RL, Mercer BM, Meis PJ, et al. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. Obstet Gynecol 1996;87:643–648.
  • Matsuura H, Hakomori SI. The oncofetal domain of fibronectin defined by the monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma. Proc Natl Acad Sci USA 1985;82:6517–6521.
  • Matsuura H, Takio K, Titani K, et al. The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. Unique structural requirement for the antigen specificity provided by a glycosylhexapeptide. J Biol Chem 1988;263:3314–3320.
  • Ruoslahti E. Fibronectin and its receptors. Ann Rev Biochem 1988;57:375–413.
  • Lockwood CJ, Senyei AE, Dische MR, et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. New Engl J Med 1991;325:669–674.
  • Feinberg RF, Kliman HJ, Lockwood CJ. Is oncofetal fibronectin a trophoblast glue for human implantation?. Am J Pathol 1991;138:537–543.
  • Morrison JC, Allbert JR, McLaughlin BN, et al. Oncofetal fibronectin in patients with false labor as a predictor of preterm delivery. Am J Obstet Gynecol 1993;168:538–542.
  • Inglis SR, Jeremias J, Kuno K, et al. Detection of tumor necrosis factor-a, interleukin-6, and fetal fibronectin in the lower genital tract during pregnancy: relation to outcome. Am J Obstet Gynecol 1994;171:5–10.
  • Iams J, Casal DC, Goodwin TM, et al. Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol 1995;173:141–145.
  • Burrus DR, Ernest JM, Veille JC. Fetal fibronectin, interluekin-6, and C-reactive protein are useful in establishing prognostic sub-categories of idiopathic preterm labor. Am J Obstet Gynecol 1995;173:1258–1262.
  • Bartnicki J, Casal D, Kreaden US, et al. Fetal fibronectin in vaginal specimens predicts preterm delivery and very low birth weight infants. Am J Obstet Gynecol 1996;174:971–974.
  • Lockwood CJ, Wein R, Lapinski R, et al. The presence of cervical and vaginal fetal fibronectin predicts preterm delivery in an inner-city obstetric population. Am J Obstet Gynecol 1993;169:798–804.
  • Leeson SC, Maresh MJA, Martindale EA, et al. Detection of fetal fibronectin as a predictor of preterm delivery in high risk asymptomatic pregnancies. Br J Obstet Gynecol 1996;103:48–53.
  • Morrison JC, Naef RW, Botti JJ, et al. Prediction of spontaneous preterm birth by fetal fibronectin and uterine activity. Obstet Gynecol 1996;87:649–655.
  • Duhig KE, Chandiramani M, Seed PT, et al. Fetal fibronectin as a predictor of spontaneous preterm labour in asymptomatic women with a cervical cerclage. BJOG 2009;116:799–803.
  • Kurtzman J, Chandiramani M, Briley A, et al. Quantitative fetal fibronectin screening in asymptomatic high-risk patients and the spectrum of risk for recurrent preterm delivery. Am J Obstet Gynecol 2009;200:263.e1–263.e6.
  • Peaceman AM, Andrews WW, Thorp JM, et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. Am J Obstet Gynecol 1997, 177:13–18.
  • Goldenberg RL, Iams JD, Mercer BM, et al. The preterm prediction study: the value of new vs. standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. Am J Public Health 1998;88:233–238.
  • Shennan A, Jones G, Hawken J, et al. Fetal fibronectin test predicts delivery before 30 weeks of gestation in high risk women, but increases anxiety. BJOG 2005;112:293–298.
  • Bolt LA, Chandiramani M, De Greeff, et al. Does fetal fibronectin testing change patient management in women at risk of preterm labour?. Eur J Obstet Gynecol Reprod Biol 2009;146:180–183.
  • Honest H, Bachmann LM, Gupta JK, et al. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. BMJ 2002;325:301.
  • Joffe GM, Jacques D, Bemis-Heys R, et al. Impact of the fetal fibronectin assay on admissions for preterm labor. Am J Obstet Gynecol 1999;180:581–586.
  • Abenhaim HA, Morin L, Benjamin A. Does availability of fetal fibronectin testing in the management of threatened preterm labour affect the utilization of hospital resources?. J Obstet Gynaecol Can 2005;27:689–694.
  • Groom KM, Liu E, Allenby K. The impact of fetal fibronectin testing for women with symptoms of preterm labour in routine clinical practice within a New Zealand population. Aust NZ J Obstet Gynaecol 2006;46:440–445.
  • NACB Laboratory Medicine Practice Guidelines. Evidence-based practice for POCT reproductive testing Available: http://www.nacb.org/lmpg/poct/chp13_repro.doc
  • Institute for Clinical Systems Improvement (ICSI). Institute for Clinical Systems Improvement, editor. Management of labor Bloomington, MN; 2005.
  • Institute for Clinical Systems Improvement. Fetal fibronectin for the prediction of preterm labor. Bloomington, MN: Institute for Clinical Systems Improvement (ICSI); 2000, Technology Assessment Report 47.
  • NICE Guidelines. Antenatal Care: routine care for the healthy pregnant woman. National Collaborating Centre for Women's and Children's Health. London; 2003.
  • NICE Guidelines. Antenatal Care: routine care for the healthy pregnant woman. National Collaborating Centre for Women's and Children's Health. London; 2008.
  • Berghella V, Hayes E, Visintine J, et al. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database Syst Rev 2008;(4):
  • Honest H, Forbes CA, Duree KH, et al. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 2009;13(43).
  • Farquarhson D, Lange I, MacDonald WA, Morin L, Simard F. SOGC Special report: preterm labour Society of Obstetricians and Gynaecologists of Canada, Special Report 2005. Society of Obstetricians and Gynaecologists of Canada.
  • Use of Cervical Fetal Fibronectin as a Screening Test for preterm Birth The RANZCOG Statement C-Obs 26, Australia, November 2008.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.